|
In spite of widespread reports of potential problems with the medication, the manufacturer of Zicam
refuses to warn users about the possible dangers of the drug. Matrixx Initiatives, the manufacturer
of Zicam, reported on their web site that the medication is "safe" in spite of an admission
that they had not conducted any studies on the loss of smell.
The manufacturer of Zicam went even further when it released a notice on February 6, 2004 "reaffirming" the
safety of Zicam. The manufacturer claimed:
Reports alleging anosmia—or loss of smell—in a small number of patients using
zinc gluconate intranasal gels for the treatment of the common cold are completely unfounded
and misleading.
These safety notices issued by Matrixx were made even though the company admitted it had not conducted
any studies on loss of smell and in the face of numerous user reports and news stories linking the
nasal spray with anosmia. |